CoChat

Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study

Ferjan, Simona, Janez, Andrej, Jensterle, Mojca · 2017 · Metabolic Syndrome and Related Disorders
Cited by 36

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: Weight loss is often nonsustainable after liraglutide cessation. The present study is the first insight into the potential prevention of weight regain in obese subjects who have been withdrawn from liraglutide. We evaluated whether dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin in adjunct to metformin prevents body weight regain more effectively than metformin alone in obese polycystic ovary syndrome (PCOS) previously treated with liraglutide. Methods: A 12-week prospective randomized open-label study was conducted with 24 obese women with PCOS who had been pretreated with liraglutide 3.0 mg due to antiobesity management (aged 34.3 ± 6.8 years, body mass index [BMI] 36.3 ± 5.2 kg/m2, mean ± standard deviation). They were randomized to combined treatment (COMBO) with sitagliptin 100 mg per day (QD) and metformin (MET) 1000 mg twice daily (BID) (n = 12) or MET 1000 mg BID (n = 12). Lifestyle intervention was promoted in both groups. The primary outcome was change in anthropometric measures of obesity. Results: Women treated with MET regain 4.7 ± 2.7 kg (P = 0.002) compared with a 0.9 ± 2.5 kg in COMBO (P = 0.147). BMI increased for 1.7 ± 0.9 kg/m2 in MET (P = 0.002) compared with 0.3 ± 0.8 kg/m2 increase in COMBO (P = 0.136). MET group regain 4.5% ± 2.5% of body weight as opposed to 0.8% ± 2.6% in COMBO. The between-treatment differences were significant for weight change (P < 0.001), percentage of weight change (P < 0.001), and BMI change (P < 0.001). Greater ability to resist emotional eating was demonstrated in COMBO. Conclusion: Sitagliptin in adjunct to metformin prevented weight regain in obese women with PCOS previously treated with liraglutide.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/met.2017.0095

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. 10.1111/dom.12119 · DOI · Paper page
  2. 10.1177/2040622315620180 · DOI · Paper page
  3. 10.1186/1475-2840-11-107 · DOI · Paper page
  4. 10.1016/j.ejphar.2014.08.010 · DOI
  5. 10.2174/1381612822666160715143933 · DOI · Paper page
  6. 10.1530/EJE-13-0797 · DOI · Paper page
  7. 10.4239/wjd.v7.i20.572 · DOI · Paper page
  8. DeFronzo R, 2014, Diabetologia, 57, 38
  9. 10.1007/s00125-015-3754-x · DOI · Paper page
  10. 10.1016/j.clinthera.2012.04.013 · DOI · Paper page
  11. 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  12. 10.2337/db13-1455 · DOI · Paper page
  13. de Lauzon B, 2004, J Nutr, 134, 2372, 10.1093/jn/134.9.2372 · DOI · Paper page
  14. 10.1046/j.1464-5491.2000.00280.x · DOI · Paper page
  15. 10.1016/0022-3999(85)90010-8 · DOI · Paper page
  16. Vickers SP, 2012, Clin Lab, 58, 787
  17. 10.1186/s12876-016-0560-y · DOI · Paper page
  18. 10.2147/VHRM.S10952 · DOI · Paper page
  19. 10.1053/j.gastro.2003.11.007 · DOI · Paper page
  20. 10.1016/S1542-3565(05)00285-5 · DOI
  21. 10.1007/s11695-007-9031-4 · DOI
  22. Wright RA, 1983, Gastroenterology, 84, 747, 10.1016/0016-5085(83)90141-5 · DOI · Paper page
  23. Tosetti C, 1996, Int J Obes Relat Metab Disord, 20, 200
  24. 10.1007/BF01249617 · DOI

Cited by

See all 36

Metadata

Authors
Ferjan, S., Janez, A., & Jensterle, M.
Venue
Metabolic Syndrome and Related Disorders
Published
2017-12
Volume
15
Issue
10
Pages
515-520
ISSN
  • 1540-4196 (ISSN-L)
  • 1557-8518
OpenAlex
W2765217575
Cited by
36
References
7
FWCI
1.89
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.